Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Lundbeck's Rexulti Growth Hopes Clouded By Dementia Agitation Data Setback
Feb 09 2018
•
By
Sten Stovall
Rexulti Needs Deciding Phase III Trial In Dementia-Related Agitation • Source: Shutterstock
More from Neurological
More from Therapeutic Category